NCT00088556 2012-05-31
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Telik
Phase 1/2 Completed
Clinical Trials
5 trialsNCT00047801 2011-07-25
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
Telik
Phase 1/2 Completed
NCT00051948 2011-07-25
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Telik
Phase 1/2 Completed
NCT00052065 2011-07-25
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer
Telik
Phase 1/2 Completed
NCT00077883 2011-07-25
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Telik
Phase 1/2 Completed